nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Angiotensin-Neprilysin Inhibition in Black Americans
|
Berardi, Cecilia |
|
|
8 |
10 |
p. 859-866 |
artikel |
2 |
Clinical Characteristics and Trends in Heart Failure Hospitalizations
|
Toner, Liam |
|
|
8 |
10 |
p. 872-875 |
artikel |
3 |
Convalescence From COVID Research
|
O’Connor, Christopher M. |
|
|
8 |
10 |
p. 870-871 |
artikel |
4 |
Effect of Dapagliflozin in Patients With HFrEF Treated With Sacubitril/Valsartan
|
Solomon, Scott D. |
|
|
8 |
10 |
p. 811-818 |
artikel |
5 |
Efficacy and Safety of Sacubitril/Valsartan by Dose Level Achieved in the PIONEER-HF Trial
|
Berg, David D. |
|
|
8 |
10 |
p. 834-843 |
artikel |
6 |
Ethnicity, Health Literacy, and Outcomes in Heart Failure
|
Williams, Stephanie M.G. |
|
|
8 |
10 |
p. 875-876 |
artikel |
7 |
Medications Are Important for Sudden Cardiac Death Prevention But So Is the Implantable Cardioverter-Defibrillator ∗
|
Al-Khatib, Sana M. |
|
|
8 |
10 |
p. 856-858 |
artikel |
8 |
NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction
|
Pascual-Figal, Domingo |
|
|
8 |
10 |
p. 822-833 |
artikel |
9 |
Quadruple Therapy Is the New Standard of Care for HFrEF ∗
|
Ahmad, Tariq |
|
|
8 |
10 |
p. 819-821 |
artikel |
10 |
Reply
|
Jing, Linyuan |
|
|
8 |
10 |
p. 877-878 |
artikel |
11 |
Reply
|
Fabbri, Matteo |
|
|
8 |
10 |
p. 876-877 |
artikel |
12 |
Sacubitril/Valsartan
|
Docherty, Kieran F. |
|
|
8 |
10 |
p. 800-810 |
artikel |
13 |
Sacubitril/Valsartan and Sudden Cardiac Death According to Implantable Cardioverter-Defibrillator Use and Heart Failure Cause
|
Rohde, Luis E. |
|
|
8 |
10 |
p. 844-855 |
artikel |
14 |
Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction
|
Mann, Douglas L. |
|
|
8 |
10 |
p. 789-799 |
artikel |
15 |
Similar Yet Different
|
Costanzo, Maria Rosa |
|
|
8 |
10 |
p. 867-869 |
artikel |
16 |
Staring Points in Heart Failure Drug Development
|
Mehmood, Muddassir |
|
|
8 |
10 |
p. 872 |
artikel |
17 |
The Competitive Advantage of Adaptability in the Approach to Heart Failure Populations
|
Mehmood, Muddassir |
|
|
8 |
10 |
p. 877 |
artikel |